Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-7-27
pubmed:abstractText
The optimal graft-versus-host disease (GVHD) prophylaxis after umbilical cord blood transplantation has not been established. Our previous observation using single calcineurin inhibitors revealed a high incidence and severity of early immune-mediated complications, especially for older patients or those with poor performance status.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1534-6080
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
366-71
pubmed:meshHeading
pubmed-meshheading:21677598-Acute Disease, pubmed-meshheading:21677598-Age Factors, pubmed-meshheading:21677598-Aged, pubmed-meshheading:21677598-Chronic Disease, pubmed-meshheading:21677598-Cord Blood Stem Cell Transplantation, pubmed-meshheading:21677598-Databases, Factual, pubmed-meshheading:21677598-Disease Progression, pubmed-meshheading:21677598-Disease-Free Survival, pubmed-meshheading:21677598-Female, pubmed-meshheading:21677598-Graft vs Host Disease, pubmed-meshheading:21677598-Hematologic Diseases, pubmed-meshheading:21677598-Humans, pubmed-meshheading:21677598-Immunosuppressive Agents, pubmed-meshheading:21677598-Incidence, pubmed-meshheading:21677598-Male, pubmed-meshheading:21677598-Matched-Pair Analysis, pubmed-meshheading:21677598-Middle Aged, pubmed-meshheading:21677598-Mycophenolic Acid, pubmed-meshheading:21677598-Pilot Projects, pubmed-meshheading:21677598-Tacrolimus
pubmed:year
2011
pubmed:articleTitle
Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone.
pubmed:affiliation
Department of Hematology, Toranomon Hospital, Minato-Ku, Tokyo, Japan. nuchida@toranomon.gr.jp
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't